Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Evaluation of Evolocumab (AMG 145) Efficacy in Diabetic Adults With Hypercholesterolemia/Mixed Dyslipidemia

ClinicalTrials.gov ID: NCT02739984

Public ClinicalTrials.gov record NCT02739984. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 3:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Evolocumab (AMG 145) on LDL-C in Subjects With Type 2 Diabetes Mellitus and Hypercholesterolemia/Mixed Dyslipidemia

Study identification

NCT ID
NCT02739984
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Amgen
Industry
Enrollment
424 participants

Conditions and interventions

Interventions

  • Evolocumab Biological
  • Placebo to Evolocumab Drug

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 16, 2016
Primary completion
Aug 2, 2017
Completion
Aug 2, 2017
Last update posted
Aug 30, 2018

2016 – 2017

United States locations

U.S. sites
46
U.S. states
23
U.S. cities
42
Facility City State ZIP Site status
Research Site Tuscumbia Alabama 35674
Research Site Phoenix Arizona 85012
Research Site Lomita California 90717
Research Site Los Angeles California 90057
Research Site Roseville California 95661
Research Site San Ramon California 94583
Research Site Spring Valley California 91978
Research Site Tarzana California 91356
Research Site Walnut Creek California 94598
Research Site Denver Colorado 80246
Research Site Lakewood Colorado 80227
Research Site Wilmington Delaware 19803
Research Site Boca Raton Florida 33434
Research Site Coral Gables Florida 33134
Research Site Daytona Beach Florida 32117
Research Site Fleming Island Florida 32003
Research Site Hollywood Florida 33021
Research Site Inverness Florida 34452
Research Site Jacksonville Florida 32216
Research Site Miami Florida 33135
Research Site Miami Florida 33136
Research Site West Palm Beach Florida 33401
Research Site Dunwoody Georgia 30338
Research Site Meridian Idaho 83642
Research Site Chicago Illinois 60611
Research Site Chicago Illinois 60612
Research Site Chicago Illinois 60616
Research Site Louisville Kentucky 40213
Research Site Auburn Maine 04210
Research Site Scarborough Maine 04074
Research Site Salisbury Maryland 21804
Research Site Methuen Massachusetts 01844
Research Site Bay City Michigan 48706
Research Site Tupelo Mississippi 38801
Research Site Las Vegas Nevada 89148
Research Site Albuquerque New Mexico 87106
Research Site New Windsor New York 12553
Research Site New York New York 10016
Research Site New York New York 10029
Research Site Shelby North Carolina 28150
Research Site Tabor City North Carolina 28463
Research Site Columbus Ohio 43203
Research Site Norman Oklahoma 73069
Research Site Austin Texas 78749
Research Site Houston Texas 77070
Research Site Suffolk Virginia 23435

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02739984, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 30, 2018 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02739984 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →